<?xml version="1.0" encoding="UTF-8"?>
<p>Although there is currently a large variety of available therapies, none of them offer complete remission to every patient. Moreover, frequent cases of treatment ineffectiveness are being reported, forcing patients to either change the medication or increase the dosage [
 <xref rid="B4-cells-09-01013" ref-type="bibr">4</xref>]. High dosage of any medication carries the risk of worsening any potential side effects. With this in mind, finding new approaches to treat chronic inflammation in IBD is imperative. As such, fecal microbiota transplantation (FMT) and phage therapy (PT) are being considered.
</p>
